Literature DB >> 11276468

Flow measurement in coronary surgery.

G D'Ancona1, H L Karamanoukian, T A Salerno, S Schmid, J Bergsland.   

Abstract

BACKGROUND: Many of the modern less invasive approaches to coronary artery bypass grafting (CABG) are performed without the use of the heart lung machine and cardiac asystole. Even after the introduction of mechanical stabilizers, the ability to achieve a technically perfect anastomosis is less certain in beating heart bypass surgery. Our group has begun to assess the surgical results of beating heart CABG using Transit Time Flow Measurement (TTFM). Our experience indicates that a meticulous and controlled method of assessing the results of intraoperative flow measurements can improve the quality of information and increases the accuracy of diagnosing technical problems with newly constructed bypass grafts. For this reason, we developed a standard algorithm for using and interpreting intraoperative TTFM.
METHODS: From January to August of 1998, 161 patients underwent off-pump CABG with a total of 323 distal anastomoses (2.0 grafts per patient). All completed grafts were tested intraoperatively with TTFM and the decision to accept or revise any individual graft was based on a decision nomogram using key values readily available from the TTFM output.
RESULTS: Thirty-two grafts (9.9%) were surgically revised based on unsatisfactory flow curves, the Pulsatile Index, or both. All revised grafts were found to have a significant technical error, such as an intimal flap, thrombus, conduit kinking, or dissection. There were no major complications, myocardial infarctions, or deaths in the entire series of patients.
CONCLUSIONS: Based on our favorable use of TTFM, we strongly recommend that patency of every graft be assessed whether the operation is performed off pump or on cardiopulmonary bypass. Guidelines for performing and interpreting TTFM ensure a high degree of confidence in the completed graft. The decision to revise a graft can be made based on simple parameters easily acquired from the TTFM device. Any concern about quality or quantity of flow should prompt immediate revision.

Entities:  

Mesh:

Year:  1999        PMID: 11276468

Source DB:  PubMed          Journal:  Heart Surg Forum        ISSN: 1098-3511            Impact factor:   0.676


  7 in total

1.  Transit Time Flowmetry in Coronary Artery Bypass Grafting-experience at Queen Alia Heart Institute, Jordan.

Authors:  Basel Harahsheh
Journal:  Oman Med J       Date:  2012-11

2.  Management [corrected] of conversions to cardiopulmonary bypass in beating heart coronary surgery.

Authors:  Emir Mujanović; Jacob Bergsland; Sanja Stanimirović-Mujanović; Emir Kabil
Journal:  Bosn J Basic Med Sci       Date:  2008-08       Impact factor: 3.363

3.  Predictors of early graft failure after coronary artery bypass grafting for chronic total occlusion.

Authors:  Hideki Oshima; Yoshiyuki Tokuda; Yoshimori Araki; Hideki Ishii; Toyoaki Murohara; Yukio Ozaki; Akihiko Usui
Journal:  Interact Cardiovasc Thorac Surg       Date:  2016-03-30

4.  Transit time flowmetry in coronary surgery--an important tool in graft verification.

Authors:  Emir Mujanović; Emir Kabil; Jacob Bergsland
Journal:  Bosn J Basic Med Sci       Date:  2007-08       Impact factor: 3.363

5.  A new way to use transit-time flow measurement for coronary artery bypass grafting.

Authors:  Lukas Stastny; Markus Kofler; Vitalijs Zujs; Elfriede Ruttmann; Julia Dumfarth; Juliane Kilo; Alexandra Brix; Simone Gasser; Adel Sakic; Thomas Schachner; Michael Grimm; Nikolaos Bonaros
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-05-10

6.  Major innovations and trends in the medical device sector.

Authors:  Jacob Bergsland
Journal:  Acta Inform Med       Date:  2012-03

7.  Evaluation of a novel laser-assisted coronary anastomotic connector - the Trinity Clip - in a porcine off-pump bypass model.

Authors:  David Stecher; Glenn Bronkers; Jappe O T Noest; Cornelis A F Tulleken; Imo E Hoefer; Lex A van Herwerden; Gerard Pasterkamp; Marc P Buijsrogge
Journal:  J Vis Exp       Date:  2014-11-24       Impact factor: 1.355

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.